In plain language
In 87 lower-limb peripheral vascular interventions, using 7.5 instead of 15 frames per second was associated with about 60% lower patient dose area product, with similar fluoroscopy time and success. Staff dose was not measured, though it likely falls in parallel.
At a glance
- Type of study
- Original research, Retrospective cohort study
- Who was studied
- Patients
- Size
- n = 87 procedures
- Summary based on
- the abstract
What it found
Median dose area product was significantly lower with 7.5 fps than with 15 fps.
Key figures: 3358 (IQR 2052-7394) vs 8812 (IQR 4944-17,370), p < 0.001
Fluoroscopy time did not differ significantly between frame rates.
Key figures: 18.7 min (IQR 11.1-31.5) vs 15.7 min (IQR 10.1-24.1), p = 0.156
Procedural success rates were comparable.
Key figures: 93.2% vs 95.3%, p > 0.999
Limits to keep in mind
Small retrospective two-center comparison of 87 procedures without randomization; only patient dose area product was measured, not operator or staff dose.
Related research summaries
- Fluoroscopy-minimization strategy for catheter ablation of Supraventricular Tachycardia by wOmen OPerators: the STOOP Multicentre Registry (2026, Prospective cohort study)
- Two Central Nervous System Tumors in One Catheter Lab: Time to Rethink Radiation Protection (2026, Retrospective cohort study)
- Radiation Awareness for EVAR in Hybrid Operating Room: An Instant Operator Risk Chart (2021, Dosimetry measurement study)
- Utilization of a Radiation Safety Time-Out Reduces Radiation Exposure During Electrophysiology Procedures (2019, Prospective cohort study)
- Completely nonfluoroscopic catheter ablation of left atrial arrhythmias and ventricular tachycardia (2018, Case report or series)
How this summary was made
ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.
Prepared November 3, 2026.